您的购物车当前为空
Ticagrelor-D7 (Standard) 是 Ticagrelor-D7 的标准品,适用于定量分析、质量控制及生化实验等相关研究。Ticagrelor-d7 是 Ticagrelor 的氘代化合物。Ticagrelor 的 CAS 号为 274693-27-5。Ticagrelor (AZD6140) 是可逆的,可口服的P2Y12受体拮抗剂,可抑制血小板聚集。
别名 替卡格雷-d7 (标准品), 替卡格雷-[d7] (标准品), Ticagrelor-[D7] (Standard)
Ticagrelor-D7 (Standard) 是 Ticagrelor-D7 的标准品,适用于定量分析、质量控制及生化实验等相关研究。Ticagrelor-d7 是 Ticagrelor 的氘代化合物。Ticagrelor 的 CAS 号为 274693-27-5。Ticagrelor (AZD6140) 是可逆的,可口服的P2Y12受体拮抗剂,可抑制血小板聚集。

| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 5,930 | 5日内发货 |
TargetMol的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。
凭借在化合物合成方面的丰富经验,我们可以根据您的研究需求为该产品提供快速定制合成服务。
| 产品描述 | Ticagrelor-D7 (Standard) is a reference standard of Ticagrelor-D7 intended for quantitative analysis, quality control, and related biochemical research applications. Ticagrelor-d7 is a deuterated compound of Ticagrelor. Ticagrelor has a CAS number of 274693-27-5. Ticagrelor, produced by AstraZeneca, is an inhibitor of platelet aggregation. Unlike clopidogrel, ticagrelor is not a prodrug required metabolic activation. The drug was approved for use in the European Union by the European Commission on December 3, 2010, and by the US FDA on July 20, 2011. Its trade names are Brilinta (US), Brilique(EU) and Possia(EU). |
| 别名 | 替卡格雷-d7 (标准品), 替卡格雷-[d7] (标准品), Ticagrelor-[D7] (Standard) |
| 分子量 | 529.61 |
| 分子式 | C23H21D7F2N6O4S |
| CAS No. | 1265911-55-4 |
| Smiles | N1C2C(N[C@@H]3C[C@H]3C3C=C(F)C(F)=CC=3)=NC(SC([2H])([2H])C([2H])([2H])C([2H])([2H])[2H])=NC=2N([C@H]2[C@H](O)[C@H](O)[C@@H](OCCO)C2)N=1 |
| 存储 | Keep away from direct sunlight Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. 实际储存温度请以COA为准 |
对于不同动物的给药剂量换算,您也可以参考 更多